Is Retrograde Intrarenal Surgery Contraindicated for Polycystic Kidney Disease?
Retrograde intrarenal surgery (RIRS) is NOT contraindicated in autosomal dominant polycystic kidney disease (ADPKD) and can be safely performed for accessible stones ≤2 cm when there is no active infection. 1
Clinical Decision Framework
Primary Considerations Before RIRS in ADPKD
Rule out active infection first – this is the critical safety step:
- Obtain both blood and urine cultures before any intervention if the patient is febrile or has elevated inflammatory markers 1, 2
- Check C-reactive protein and white blood cell count; CRP ≥50 mg/L or WBC >11 × 10⁹/L suggests cyst infection rather than simple UTI 1, 2
- Perform renal imaging (ultrasound, CT, or MRI) to differentiate between cyst infection, cyst hemorrhage, and nephrolithiasis, as all three can present with similar symptoms 1, 2
- If cyst infection is confirmed, delay stone intervention until completing 4–6 weeks of lipid-soluble antibiotics (trimethoprim-sulfamethoxazole or fluoroquinolones) 1, 2
When RIRS Is Appropriate in ADPKD
For stones ≤2 cm in accessible calyces with preserved renal function and no infection, RIRS is a valid first-line option:
- The AUA/Endourological Society guidelines recommend ureteroscopy (URS/RIRS) for symptomatic stones ≤10 mm in any location, including lower pole 1
- RIRS has been successfully used in ADPKD patients with complete stone clearance in multiple case series 3
- A single-center study of 19 ADPKD patients with nephrolithiasis reported successful outcomes with URS and RIRS without major complications over 4.2 years mean follow-up 3
Technical Considerations Specific to ADPKD
The distorted anatomy from cysts requires careful technique but does not preclude RIRS:
- Normal saline irrigation must be used (never glycine or water) to prevent hemolysis and electrolyte abnormalities if significant absorption occurs through cyst rupture 1
- Flexible ureteroscopy allows navigation around cysts to reach stone-bearing calyces 4, 5
- RIRS may require staged procedures in ADPKD due to anatomic complexity, but this does not constitute a contraindication 1
Alternative Treatment Selection
When RIRS may not be optimal in ADPKD:
- Stones >20 mm total burden: PCNL becomes first-line therapy per AUA guidelines, though PCNL in ADPKD carries theoretical bleeding risk from cyst puncture 1
- Lower pole stones >10 mm: SWL should not be first-line (58% success rate vs 81% for URS); RIRS or PCNL are preferred 1
- Complicated nephrolithiasis with recurrent infection: Consider nephrectomy only if the kidney has negligible function 1
Common Pitfalls to Avoid
Do not confuse cyst infection with UTI – this is the most critical error in ADPKD stone management:
- Standard UTIs in ADPKD require only ≤7 days of antibiotics (nitrofurantoin, TMP-SMX, or fosfomycin) 1, 2
- Cyst infections require 4–6 weeks of lipid-soluble antibiotics and may need percutaneous drainage if unresponsive 1, 2
- Performing RIRS during active cyst infection risks sepsis; always obtain cultures and inflammatory markers first 1, 2
Avoid fluoroquinolone overuse – while these agents penetrate cysts well, the KDIGO 2025 guideline specifically warns that fluoroquinolones increase risk of tendinopathy and aortic aneurysm/dissection in ADPKD patients who already have underlying vascular abnormalities 1, 2
Do not use chronic NSAIDs for pain control in ADPKD patients undergoing stone management, as they cause renal adverse effects 2
Practical Algorithm for Stone Management in ADPKD
- Assess for infection: Check CRP, WBC, blood and urine cultures 1, 2
- Image the kidneys: Rule out cyst hemorrhage and localize stones 1, 2
- If infection present: Treat with appropriate antibiotics for 4–6 weeks before stone intervention 1, 2
- If no infection and stone ≤2 cm in accessible calyx: RIRS is appropriate first-line therapy 1, 3
- If stone >20 mm or complex anatomy: Consider PCNL with awareness of bleeding risk from cyst puncture 1
- Use normal saline irrigation only during any endoscopic procedure 1